⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ps 2

Every month we try and update this database with for ps 2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
1st Line Durvalumab in PS 2 NSCLC PatientsNCT03620669
NSCLC Stage IV
NSCLC Stage III...
Durvalumab
18 Years - Swiss Group for Clinical Cancer Research
1st Line Durvalumab in PS 2 NSCLC PatientsNCT03620669
NSCLC Stage IV
NSCLC Stage III...
Durvalumab
18 Years - Swiss Group for Clinical Cancer Research
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.NCT00269828
NSCLC
paclitaxel
paclitaxel poli...
18 Years - CTI BioPharma
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: